Biological characterization of new inhibitors of microsomal PGE synthase‐1 in preclinical models of inflammation and vascular tone-Reference-Cited by-同舟云学术

Biological characterization of new inhibitors of microsomal PGE synthase‐1 in preclinical models of inflammation and vascular tone

Published:2019-12 Issue:24 Volume:176 Page:4625-4638
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Larsson Karin¹,Steinmetz Julia¹,Bergqvist Filip¹^ORCID,Arefin Samsul²,Spahiu Linda³,Wannberg Johan⁴,Pawelzik Sven‐Christian¹⁵,Morgenstern Ralf³,Stenberg Patric⁶,Kublickiene Karolina²,Korotkova Marina¹,Jakobsson Per‐Johan¹

Affiliation:

1. Rheumatology Unit, Department of Medicine, Solna, Karolinska InstitutetKarolinska University Hospital Stockholm Sweden

2. Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska InstitutetKarolinska University Hospital Stockholm Sweden

3. Biochemical Toxicology Unit, Institute of Environmental MedicineKarolinska Institutet Stockholm Sweden

4. SciLifeLab Drug Discovery and Development Platform, Medicinal Chemistry—Lead Identification, Department of Medicinal ChemistryUppsala University Uppsala Sweden

5. Theme Heart and Vessels, Division of Valvular and Coronary DiseasesKarolinska University Hospital Stockholm Sweden

6. Gesynta Pharma AB Solna Sweden

Funder

Innovative Medicines Initiative

Karolinska Institutet

Vetenskapsrådet

VINNOVA

Stockholms Läns Landsting

Cancerföreningen i Stockholm

Cancerfonden

Barncancerfonden

Stiftelsen Konung Gustaf V:s 80-årsfond